HEPATITIS
(
SEVAMED 2002)
(Diagnosis,
Diagnostics, Immunodiagnosis, Immunodiagnostics, Pathogenesis,
Vaccines & Drugs)
3259.
Akuta N. Chayama K. Suzuki
F. Someya T.
Kobayashi M. Tsubota A.
Suzuki Y. Saitoh S. Arase Y.
Ikeda K. Kumada H. Risk
factors of hepatitis C virus-related liver cirrhosis in young adults: positive
family history of liver disease and transporter associated with antigen
processing 2(TAP2)*0201 Allele. Journal of Medical Virology. 64(2):109-16, 2001
Jun.
3260.
Al-Sheyyab M. Batieha A. El-Khateeb
M. The prevalence of hepatitis B,
hepatitis C and human immune deficiency virus markers in multi-transfused
patients. Journal of Tropical
Pediatrics. 47(4):239-42, 2001 Aug.
3261.
Andries S. Casamayou L.
Sempoux C. Burlet M.
Reding R. Bernard Otte J. Buts
JP. Sokal E. Posttransplant immune
hepatitis in pediatric liver transplant recipients: incidence and maintenance
therapy with azathioprine. Transplantation.
72(2):267-72, 2001 Jul 27.
3262.
Andriulli A. Festa V.
Leandro G. Rizzetto M. Usefulness
of a liver biopsy in the evaluation of patients with elevated ALT values and
serological markers of hepatitis viral infection: an AIGO study.
Digestive Diseases & Sciences. 46(7):1409-15,
2001 Jul.
3263.
Aoyagi K. Iida K. Ohue C.
Matsunaga Y. Tanaka E.
Kiyosawa K. Yagi S. Performance of
a conventional enzyme immunoassay for hepatitis C virus core antigen in the
early phases of hepatitis C infection. Clinica y Laboratorio.
47(3-4):119-27, 2001.
3264.
Arens M. Clinically relevant
sequence-based genotyping of HBV, HCV, CMV, and HIV. [Review] [62 refs] Journal
of Clinical Virology. 22(1):11-29,
2001 Aug.
3265.
Badur S. Akgun A. Diagnosis
of hepatitis B infections and monitoring of treatment. [Review] [33 refs]
Journal of Clinical Virology. 21(3):229-37,
2001 Jun.
3266.
Barrett S. Goh J. Coughlan
B. Ryan E.
Stewart S. Cockram A. O'Keane
JC. Crowe J. The natural course of
hepatitis C virus infection after 22 years in a unique homogenous cohort:
spontaneous viral clearance and chronic HCV infection. Gut.
49(3):423-30, 2001 Sep.
3267. Bhatia V, Swami H M. Assessment of hepatitis B vaccine coverage by using the national immunization day in Chandigarh. Indian J med Sci. 54(8): 347-9, 2000.
3268.
Cantaloube JF. Gallian P.
Attoui H. Biagini P.
De Micco P. De Lamballerie X. Erroneous HCV genotype assignment by a
hybridization typing assay in a case of posttransfusion HCV infection.
Transfusion. 41(3):429-30,
2001 Mar.
3269.
Cashman TM. Elm JL Jr. Wu M.
Tom T. Effler PV. Hepatitis
C, diagnosis and management: a survey of practicing physicians in Hawaii.
Hawaii Medical Journal. 60(6):148-54,
2001 Jun.
3270. Chandrasekaran S, Palaniappan N, Krishnan V, Mohan G, Chandrasekaran N. Relative prevalence of hepatitis B viral markers and hepatitis C virus antibodies(anti HCV) in Madurai, south India. Indian J med Sci. 54(7): 270-3, 2000.
3271. Chitambar S D, Chadha M S. Use of filter paper disc for hepatitis A surveillance. Indian J Gastroenterol.19(4):165-7, 2000.
3272.
Cho JW. Baek WK. Suh SI.
Yang SH. Chang J. Sung YC.
Suh MH. Hepatitis C virus
core protein promotes cell proliferation through the upregulation of cyclin E
expression levels. Liver.
21(2):137-42, 2001 Apr.
3273.
Chu CW. Hwang SJ.
Luo JC. Lai CR.
Tsay SH. Li CP. Wu JC.
Chang FY. Lee SD. Clinical, virologic, and pathologic significance of
elevated serum alpha-fetoprotein levels in patients with chronic hepatitis C.
Journal of Clinical Gastroenterology.
32(3):240-4, 2001 Mar.
3274.
Du B. You S. Present
situation in preventing and treating liver fibrosis with TCM drugs. [Review] [26
refs] Journal of Traditional
Chinese Medicine. 21(2):147-52, 2001 Jun.
3275.
Erensoy S. Diagnosis of
hepatitis C virus (HCV) infection and laboratory monitoring of its therapy.
[Review] [45 refs] Journal of
Clinical Virology. 21(3):271-81,
2001 Jun.
3276.
Fabrizi F. Martin P. Dixit
V. Quan S.
Brezina M. Kaufman E. Sra K.
Mousa M. DiNello R. Polito
A. Gitnick G. Automated RIBA HCV strip
immunoblot assay: a novel tool for the diagnosis of hepatitis C virus infection
in hemodialysis patients. American Journal of Nephrology.
21(2):104-11, 2001 Mar-Apr.
3277.
Funato T. Satou N. Abukawa
D. Satou J.
Abe Y. Ishii KK. Iinuma K.
Kaku M. Sasaski T. Quantitative
evaluation of cytomegalovirus DNA in infantile hepatitis. Journal of Viral
Hepatitis. 8(3):217-22, 2001 May.
3278.
Gopalani A. Ahuja TS.
Prevalence of glomerulopathies in autopsies of patients infected with the
hepatitis C virus. American Journal
of the Medical Sciences. 322(2):57-60,
2001 Aug.
3279.
Hahn JA. Page-Shafer K.
Lum PJ. Ochoa K.
Moss AR. Hepatitis C virus infection and needle exchange use among young
injection drug users in San Francisco. Hepatology.
34(1):180-7, 2001 Jul.
3280.
Halfon P. Trimoulet P.
Bourliere M. Khiri H.
de Ledinghen V. Couzigou P.
Feryn JM. Alcaraz P.
Renou C. Fleury HJ. Ouzan D.
Hepatitis C virus genotyping based on 5' noncoding sequence analysis (Trugene).
Journal of Clinical Microbiology. 39(5):1771-3,
2001 May.
3281.
Hitzler WE. Runkel S.
Routine HCV PCR screening of blood donations to identify early HCV infection in
blood donors lacking antibodies to HCV. Transfusion.
41(3):333-7, 2001 Mar.
3282. Kapoor S, Gupta R K, Das B C, Kar P. Clinical implications of hepatitis G virus (HGV) infection in patients of acute viral hepatitis and fulminant hepatic failure. Indian J med Res. 112(Oct): 121-32, 2001.
3283. Kocak N, Ozen H, Saltik I N, Yuce A, Gurakan F. Recombinant interferon-alfa therapy in children with chronic hepatitis B and cured cancer. Indian J Gastroenterol.19(4): 197-8, 2000.
3284.
Koff RS. Risks associated with hepatitis A and hepatitis B in patients
with hepatitis C. [Review] [36 refs] Journal
of Clinical Gastroenterology. 33(1):20-6,
2001 Jul.
3285.
Kozlowski A. Charles SA.
Harris JM. Development of pegylated
interferons for the treatment of chronic hepatitis C. [Review] [46 refs]
Biodrugs. 15(7):419-29,
2001.
3286.
Levis J. Kenny-Walsh E.
O'Sullivan K. Horgan M.
Whelton M. Shanahan F.
Fanning L. Strategy for the maximization of clinically relevant
information from hepatitis C virus, RT-PCR quantification. Journal of Clinical
Virology. 20(3):163-71, 2001 Feb.
3287.
Lieber CS. Liver diseases by alcohol and hepatitis C: early detection and
new insights in pathogenesis lead to improved treatment. [Review] [152 refs]
American Journal on Addictions. 10
Suppl:29-50, 2001.
3288. Mathur V K, Vyas P D. Hepatitis B vaccines: what is new. SDMH JI. 23(3), 6-10,1999.
3289. Naik S R. Hepatitis B virus : Infected or just carrying. Indian J Gastroenterol. 19(3): 130-2, 2000.
3290.
Polywka S. Schroter M.
Feucht HH. Zollner B.
Laufs R. Relevance of reactivity in commercially available hepatitis C
virus antibody assays. Journal of Clinical Microbiology.
39(4):1665-8, 2001 Apr.
3291. Raina V. Purification and properties of recombinant hepatitis A 14s subunit protein. Proc natn Acad Sci India-Sect B.69(1): 27-36, 1999.
3292.
Rostaing L. Borde JS. Hasle
C. Bories P.
Allal A. Abbal M. Durand D.
Lack of effect of chronic hepatitis C virus infection on T-cell cytokine
production in chronic hemodialysis patients. American Journal of Nephrology.
21(3):194-9, 2001 May-Jun.
3293.
Ryan M. Desmond P. Liver
toxicity. Could this be a drug reaction?. [Review] [8 refs] Australian Family
Physician. 30(5):427-31, 2001 May.
3294.
Saab S. Brezina M. Gitnick
G. Martin P.
Yee HF Jr. Hepatitis C screening strategies in hemodialysis patients.
[see comments]. American Journal of Kidney Diseases.
38(1):91-7, 2001 Jul.
3295.
Sagnelli E. Coppola N.
Scolastico C. Mogavero AR.
Filippini P. Piccinino F.
HCV genotype and "silent" HBV coinfection: two main risk factors for a
more severe liver disease. Journal of Medical Virology.
64(3):350-5, 2001 Jul.
3296.
Schroter M. Schafer P.
Zollner B. Polywka S.
Laufs R. Feucht HH. Strategies
for reliable diagnosis of hepatitis C infection: the need for a serological
confirmatory assay. Journal of Medical Virology.
64(3):320-4, 2001 Jul.
3297.
Sheiner PA. Florman SS. Emre
S. Fishbein T.
Schwartz ME. Miller CM.
Boros P. Recurrence of hepatitis C after liver transplantation is
associated with increased systemic IL-10 levels. Mediators of Inflammation.
10(1):37-41, 2001 Feb.
3298.
Singh VK. Naik S.
Simultaneous amplification of DNA and RNA virus using multiplex PCR system.
Clinica Chimica Acta. 308(1-2):179-81, 2001 Jun.
3299.
Smythe JS. Anstee DJ.
Expression of C antigen in transduced K562 cells. Transfusion.
41(1):24-30, 2001 Jan.
3300. Sobao Y. Tomiyama H. Nakamura S. Sekihara H. Tanaka K. Takiguchi M. Visual demonstration of hepatitis C virus-specific memory CD8(+) T-cell expansion in patients with acute hepatitis C. Hepatology. 33(1):287-94, 2001 Jan.
3301.
Teixeira R. Papatheodoridis
GV. Burroughs AK. Management of
recurrent hepatitis C after liver transplantation. [Review] [88 refs]
Journal of Viral Hepatitis. 8(3):159-68,
2001 May.
3302.
Tennant BC. Gerin JL. The
woodchuck model of hepatitis B virus infection. [Review] [214 refs]
Ilar Journal. 42(2):89-102,
2001.
3303.
Torre F. Giusto R. Grasso A.
Brizzolara R. Campo N.
Sinelli N. Balestra V.
Picciotto A. Clearance kinetics of hepatitis C virus under different
antiviral therapies. Journal of Medical Virology.
64(4):455-9, 2001 Aug.
3304.
Walsh K. Alexander GJ.
Update on chronic viral hepatitis. [Review] [101 refs] Postgraduate
Medical Journal. 77(910):498-505, 2001 Aug.
3305.
Wang QM. Heinz BA. Recent
advances in prevention and treatment of hepatitis C virus infections. [Review]
[159 refs] Progress in Drug Research. Spec
No:79-110, 2001.
3306.
Weber B. Melchior W. Gehrke
R. Doerr HW.
Berger A. Rabenau H. Hepatitis B virus markers in anti-HBc only positive
individuals. Journal of Medical Virology. 64(3):312-9, 2001 Jul.
3307.
Wendland BE. Nutritional
guidelines for persons infected with the hepatitis C virus: a review of the
literature. [Review] [80 refs] Canadian Journal of Dietetic Practice &
Research. 62(1):7-15, 2001 Spring.
3308. Willers E. Webber L. Delport R. Kruger M. Hepatitis B--a major threat to childhood survivors of leukaemia/lymphoma. Journal of Tropical Pediatrics. 47(4):220-5, 2001 Aug.
Apr
02
4052.
Agarwal M K, Bhatt V B, Agrawal A
S : Hepatitis E. Gujarat med J 2000, 57(1), 21-3. (016248) Aug 16, 2023
4053.
Anand P, Thakur S K, Jaiprakash M, Sharma U K, Rajvanshi A, Gill H S,
Narula A S: Hepatitis C in chronic renal failure and renal transplant recipents.
Indain J Gastroenterl 1999, 18(1 Suppl), S35. (016255) Aug 16, 2023
4054.
Arora N K, Mathur P, Arora N, Panda
S K: Hepatitis C virus (HCV) infection in children in North India. Indian J
Gastroenterol 1999,18(1 Suppl), S35. (016260) Aug 16, 2023
4055.
Arrankalle V A, Deshmukh T M, Chobe L P, Chadha M S, Walambe A M:
Hepatitis G virus infection in India: prevalence and phylogenetic analysis based
on 5’ non-coading region. Indian J Gastroenterol 2001,20(1), 13-17. (016259)
Aug 16, 2023
4056.
Bapat S, Joshi D, Naik SS, Bavdekar A, Bhave S, Pandit A. Hepatitis B
immunization in adolescent girls. Indian Pediatr
2001 Oct;38(10):1160-2
4057.
Bouchard MJ, Wang LH, Schneider RJ. Calcium signaling by HBx protein in
hepatitis B virus DNA replication. Science
2001 Dec 14;294(5550):2376-8
4058.
Bruno R, Sacchi P, Malfitano A, Filice G. YMDD-mutant HBV strain as a
cause of liver failure in an HIV-infected patient. Gastroenterology 2001
Oct;121(4):1027-8
4059.
Butz K, Denk C, Fitscher B, Crnkovic-Mertens I, Ullmann A, Schroder CH,
Hoppe Seyler F. Peptide aptamers targeting the hepatitis B virus core protein: a
new class of molecules with antiviral activity. Oncogene 2001 Oct
4;20(45):6579-86
4060.
Carroccio A, Giannitrapani L, Soresi M, Not T, Iacono G, Di Rosa C,
Panfili E, Notarbartolo A, Montalto G. Guinea pig transglutaminase immunolinked
assay does not predict coeliac disease in patients with chronic liver disease.
Gut 2001 Oct;49(4):506-11
4061.
Chedid A, Sung CC, Lepe MR, Ahmed SA, Iftikhar SA, Feller A, Beaman KD.
Expression of a novel protein by regenerating hepatocytes and peripheral blood
lymphocytes. Clin Diagn Lab Immunol 2001
Nov;8(6):1292-4
4062.
Chen GG, Lai PB, Chak EC, Xu H, Lee KM, Lau WY. Immunohistochemical
analysis of pro-apoptotic Bid level in chronic hepatitis, hepatocellular
carcinoma and liver metastases. Cancer Lett
2001 Oct 22;172(1):75-82
4063.
Choudhuri G, Saraswat V A, Lakhtakia S, Dadhich S K, Mehrotra P, Naik S
R: Poor response to low dose interferon therapy in chronic liver disease due to
hepatitis B virus infection in Indian patients. Indian J Gastroenterol 1999,
18(1 Suppl), S26. (016288) Aug 16, 2023
4064.
Comanor L, Anderson F, Ghany M, Perrillo R, Heathcote EJ, Sherlock C,
Zitron I, Hendricks D, Gordon SC. Transcription-mediated amplification is more
sensitive than conventional PCR-based assays for detecting residual serum HCV
RNA at end of treatment. Am J Gastroenterol
2001 Oct;96(10):2968-72
4065.
Crespo J, Cayon A, Fernandez-Gil P, Hernandez-Guerra M, Mayorga M,
Dominguez Diez A, Fernandez-Escalante JC, Pons-Romero F. Gene expression of
tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic
steatohepatitis patients. Hepatology 2001
Dec;34(6):1158-63
4066.
Davis GL. Treatment of chronic hepatitis C. BMJ 2001 Nov
17;323(7322):1141-2
4067.
De Silvestri A, Pasi A, Martinetti M, Belloni C, Tinelli C, Rondini G,
Salvaneschi L, Cuccia M. Family study of non-responsiveness to hepatitis B
vaccine confirms the importance of HLA class III C4A locus. Genes Immun
2001 Nov;2(7):367-72
4068.
Faustini A, Spadea T, Fano V, Giorgi Rossi P, Sangalli M, Franco E,
Perucci CA. Factors associated with hepatitis B virus immunization coverage at
the beginning of a population campaign in the Lazio region, Italy. Prev Med
2001 Nov;33(5):409-14
4069.
Friebe P, Lohmann V, Krieger N, Bartenschlager R. Sequences in the 5'
nontranslated region of hepatitis C virus required for RNA replication. J Virol
2001 Dec;75(24):12047-57
4070.
Goddard S, Williams A, Morland C, Qin S, Gladue R, Hubscher SG, Adams DH.
Differential expression of chemokines and chemokine receptors shapes the
inflammatory response in rejecting human liver transplants. Transplantation 2001
Dec 27;72(12):1957-67
4071.
Govindarajan R, Naik S:
Modulation of tumor necrosis factor-a
production by hepatitis B virus in human monocytic cell line, THP-1. Indian J
Gastroenterol 1999, 18(1 Suppl), S22. (016330) Aug 16, 2023
4072.
Greenberg DP. Considerations for hepatitis B as part of a combination
vaccine. Pediatr Infect Dis J 2001
Nov;20(11 Suppl):S34-9
4073.
Gupta DK, Charles AR, Srinivas M, Dave S, Bal CS. Betamethasone in plus
phenobarbitone prior to hepatobiliary scintigraphy increases diagnostic accuracy
in infants with jaundice. Indian J Pediatr
2001 Nov;68(11):1039-41
4074.
Harjeet Singh, Pradhan M, Naik S: Antibody response to hepatitis B
vaccine in thalassemic children. Indian J Gastroenterol 1999, 18(1 Suppl), S22.
(016341) Aug 16, 2023
4075.
Jacobs RJ, Meyerhoff AS. Comparative cost effectiveness of varicella,
hepatitis A, and pneumococcal conjugate vaccines. Prev Med 2001 Dec;33(6):639-45
4076.
Jaiswal S P, Chitnis D S, Naik G, Jain A, Salgia P, Sepaha A: Hepatitis B
and Cvirus scenario in central India. Indian J Gastroenterol 1999, 18(1 Suppl),
S38-40. (016350) Aug 16, 2023
4077.
Jhamb U, Malhotra V, Mittal S K: Hepatitis B and C in childhood chronic
liver disease. Indian J Gastroenterol 1999, 18(1 Suppl), S40. (016355) Aug 16,
2001
4078.
Jolivet-Reynaud C, Lesenechal M, O'Donnell B, Becquart L, Foussadier A,
Forge F, Battail-Poirot N, Lacoux X, Carman W, Jolivet M. Localization of
hepatitis B surface antigen epitopes present on variants and specifically
recognised by anti-hepatitis B surface antigen monoclonal antibodies. J Med
Virol 2001 Oct;65(2):241-9
4079.
Joshi N, Ajit Kumar, Rao N, Girish Narayan M, Nagarjun Kumar Y R, Babu S:
Efficacy of the 1st indigenously developed recombinant vaccine
against hepatitis B virus in Indian subjects. Indian J Gastroenterol 1999, 18(1
Suppl), S24-5.(016356) Aug 16, 2023
4080.
Kato H, Orito E, Sugauchi F, Ueda R, Gish RG, Usuda S, Miyakawa Y,
Mizokami M. Determination of hepatitis B virus genotype G by polymerase chain
reaction with hemi-nested primers. J Virol Methods 2001 Nov;98(2):153-9
4081.
Kuffner EK, Dart RC, Bogdan GM, Hill RE, Casper E, Darton L. Effect of
maximal daily doses of acetaminophen on the liver of alcoholic patients: a
randomized, double-blind, placebo-controlled trial. Arch Intern Med 2001 Oct
8;161(18):2247-52
4082.
Li C, Candotti D, Allain JP. Production and characterization of
monoclonal antibodies specific for a conserved epitope within hepatitis C virus
hypervariable region 1. J Virol 2001
Dec;75(24):12412-20
4083.
Li D, Mallory T, Satomura S. AFP-L3: a new generation of tumor marker for
hepatocellular carcinoma. Clin Chim Acta 2001 Nov;313(1-2):15-9
4084.
Lieber CS. Alcoholic liver injury: pathogenesis and therapy in 2001.
Pathol Biol (Paris) 2001
Nov;49(9):738-52
4085.
Madan K, Jain A, Jandwani P, Gupta R K, Kar P, Mathur U S: Multicentric
open labelled evaluation of immunogenicity (seroprotection rate) and
reactogenicity of a recombinant DNA hepatitis B vaccine of Cuban origin when
administered in a two dose schedule. Indian J Gastroenterol 1999, 18(1 Suppl),S24.
) (016378) Aug 16, 2023
4086.
Mathur P, Arora N K: Consideration for HAV vaccine in India. Indian J
Pediat 2001, 68(1),23-30. (016392) Aug 16, 2023
4087.
Mawhorter SD. Who should receive hepatitis A vaccine? Cleve Clin J Med
2001 Oct;68(10):825-7
4088.
Mele A, Tancredi F, Romano L, Giuseppone A, Colucci M, Sangiuolo A, Lecce
R, Adamo B, Tosti ME, Taliani G, Zanetti AR. Effectiveness of hepatitis B
vaccination in babies born to hepatitis B surface antigen-positive mothers in
Italy. J Infect Dis 2001 Oct
1;184(7):905-8
4089.
Mittal S K: Desirability and fesibility of hepatitis B vaccine in EPI.
Indian J Pediat 2001, 68(1), 61-5. (016400) (No abstract) Aug 16, 2023
4090.
Nair S, Perrillo RP. Serum alanine aminotransferase flares during
interferon treatment of chronic hepatitis B: is sustained clearance of HBV DNA
dependent on levels of pretreatment viremia? Hepatology 2001 Nov;34(5):1021-6
4091.
Rajan S, Liebman HA. Treatment of hepatitis C related thrombocytopenia
with interferon alpha. Am J Hematol 2001
Nov;68(3):202-9
4092.
Ray S, Broor S, Ghosh D, Vaisnav Y, Broor S L, Dar L, Seth P: TGF b
levels in HCV related chronic liver disease as studied by semiquantitative
RT-PCR. Indian J Gastroenterol 1999, 18(1 Suppl), S33. (016455) Aug 16, 2023
4093.
Sewell EC, Jacobson SH, Weniger BG. "Reverse engineering" a
formulary selection algorithm to determine the economic value of pentavalent and
hexavalent combination vaccines. Pediatr Infect Dis J
2001 Nov;20(11 Suppl):S45-56
4094.
Sleijffers A, Garssen J, de Gruijl FR, Boland GJ, van Hattum J, van
Vloten WA, van Loveren H. Influence of ultraviolet B exposure on immune
responses following hepatitis B vaccination in human volunteers. J Invest
Dermatol 2001 Nov;117(5):1144-50
4095.
Thakur S K, Gupta R M, Rao M K K, Dham S K: Hepatitis B carrier-a study
of possible routes of acquiring the infection. Indian J Gastroenterol 1999, 18(1
Suppl), S23. (016520) Aug 16, 2023
4096.
Torre D, Tambini R, Cadario F, Barbarini G, Moroni M, Basilico C.
Evolution of coinfection with human immunodeficiency virus and hepatitis C virus
in patients treated with highly active antiretroviral therapy. Clin Infect Dis
2001 Nov 1;33(9):1579-85
4097.
Webster G, Bertoletti A. Quantity and quality of virus-specific CD8 cell
response: relevance to the design of a therapeutic vaccine for chronic HBV
infection. Mol Immunol 2001
Dec;38(6):467-73
4098.
Zimet GD, Kee R, Winston Y, Perkins SM, Maharry K. Acceptance of
hepatitis B vaccination among adult patients with sexually transmitted diseases.
Sex Transm Dis 2001
Nov;28(11):678-80
4099.
Zmuda JF, Wagoneer B, Liotta L, Whiteley G. Recognition of multiple
classes of hepatitis C antibodies increases detection sensitivity in oral fluid.
Clin Diagn Lab Immunol 2001
Nov;8(6):1267-70
4100.
Zuckerman JN, Zuckerman AJ, Symington I, Du W, Williams A, Dickson B,
Young MD; UK Hepacare Study Group. Evaluation of a new hepatitis B
triple-antigen vaccine in inadequate responders to current vaccines. Hepatology
2001 Oct;34(4 Pt 1):798-802
July
02
4608.
Aceti A, Pasquazzi C, Zechini B, De Bac C. Hepatotoxicity development
during antiretroviral therapy containing protease inhibitors in patients with
HIV: the role of hepatitis B and C virus infection. J Acquir Immune Defic Syndr.
2002 Jan 1;29(1):41-8.
4609.
Almroth G, Ekermo B, Mansson AS, Svensson G, Widell A. Detection and
prevention of hepatitis C in dialysis patients and renal transplant recipients.
A long-term follow up (1989-January 1997). J Intern Med. 2002 Feb;251(2):119-28.
4610.
Alzahrani AJ, Vallely PJ, McMahon RF. Development of a novel nested in
situ PCR-ISH method for detection of hepatitis C virus RNA in liver tissue. J
Virol Methods. 2002 Jan;99(1-2):53-61.
4611.
Angelico M, Di Paolo D, Trinito MO, Petrolati A, Araco A, Zazza S,
Lionetti R, Casciani CU, Tisone G. Failure
of a reinforced triple course of hepatitis B vaccination in patients
transplanted for HBV-related cirrhosis. Hepatology. 2002 Jan;35(1):176-81.
4612.
Aoki M, Saito T, Watanabe H, Matsuo T, Saito K, Togashi H, Kawata S,
Ishikawa K, Aoyama M, Kamada H, Shinzawa H. Clinical significance of a highly
sensitive enzyme immunoassay of hepatitis B surface antigen using a novel
electron spin resonance technique. J Med Virol. 2002 Feb;66(2):166-70.
4613.
Bernstein D, Kleinman L, Barker CM, Revicki DA, Green J. Relationship of
health-related quality of life to treatment adherence and sustained response in
chronic hepatitis C patients. Hepatology. 2002 Mar;35(3):704-8.
4614.
Bluteau O, Beaudoin JC, Pasturaud P, Belghiti J, Franco D, Bioulac-Sage
P, Laurent-Puig P, Zucman-Rossi J. Specific association between alcohol intake,
high grade of differentiation and 4q34-q35 deletions in hepatocellular
carcinomas identified by high resolution allelotyping. Oncogene. 2002 Feb
14;21(8):1225-32.
4615.
Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M, Artini M,
Almerighi C, Verkerk R, Meltzer H, Maes M. Increased depressive ratings in
patients with hepatitis C receiving interferon-alpha-based immunotherapy are
related to interferon-alpha-induced changes in the serotonergic system. J Clin
Psychopharmacol. 2002 Feb;22(1):86-90.
4616.
Bonkovsky HL. Iron as a comorbid factor in chronic viral hepatitis. Am J
Gastroenterol. 2002 Jan;97(1):1-4.
4617.
Brinster C, Chen M, Boucreux D, Paranhos-Baccala G, Liljestrom P,
Lemmonier F, Inchauspe G. Hepatitis C virus non-structural protein 3-specific
cellular immune responses following single or combined immunization with DNA or
recombinant Semliki Forest virus particles. J Gen Virol. 2002 Feb;83(Pt
2):369-81.
4618.
Buchanan D, Khoshnood K, Stopka T, Shaw S, Santelices C, Singer M.
Ethical dilemmas created by the criminalization of status behaviors: case
examples from ethnographic field research with injection drug users. Health Educ
Behav. 2002 Feb;29(1):30-42.
4619.
Cardin R, D'Errico A, Fiorentino M, Cecchetto A, Naccarato R, Farinati F.
Hepatocyte proliferation and apoptosis in relation to oxidative damage in
aalcohol-related liver disease Alcohol Alcohol. 2002 Jan-Feb;37(1):43-8.
4620.
Carvajal GP, Garcia D, Sanchez SA, Velasco MA, Rueda D, Lucena MI.
Hepatotoxicity associated with the new antidepressants. J Clin Psychiatry. 2002
Feb;63(2):135-7.
4621.
Chamberland ME. Emerging infectious agents: do they pose a risk to the
safety of transfused blood and blood products? Clin Infect Dis. 2002 Mar
15;34(6):797-805.
4622.
Chan HL. Changing scene in hepatitis B serology interpretation. Hosp Med.
2002 Jan;63(1):16-9. Review.
4623.
Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung
C, Karim R, Lin R, Samarasinghe D, Liddle C, Weltman M, George J. NASH and
insulin resistance: Insulin hypersecretion and specific association with the
insulin resistance syndrome. Hepatology. 2002 Feb;35(2):373-9.
4624.
Cody SH, Nainan OV, Garfein RS, Meyers H, Bell BP, Shapiro CN, Meeks EL,
Pitt H, Mouzin E, Alter MJ, Margolis HS, Vugia DJ. Hepatitis C virus
transmission from an anesthesiologist to a patient. Arch Intern Med. 2002 Feb
11;162(3):345-50.
4625.
Czaja AJ, Donaldson PT, Lohse AW. Antibodies to soluble liver
antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis. Am
J Gastroenterol. 2002 Feb;97(2):413-9.
4626.
Dai CY, Yu ML, Chuang WL, Hou NJ, Hou C, Chen SC, Lin ZY, Hsieh MY, Wang
LY, Chang WY. The response of
hepatitis C virus and TT virus to high dose and long duration interferon-alpha
therapy in naive chronic hepatitis C patients. Antiviral Res. 2002
Jan;53(1):9-18.
4627.
Dandri M, Burda MR, Burkle A, Zuckerman DM, Will H, Rogler CE, Greten H,
Petersen J. Increase in de novo HBV DNA integrations in response to oxidative
DNA damage or inhibition of poly(ADP-ribosyl)ation. Hepatology. 2002
Jan;35(1):217-23.
4628.
Di Bisceglie AM, McHutchison J, Rice CM. New therapeutic strategies for
hepatitis C. Hepatology. 2002 Jan;35(1):224-31. Review.
4629.
Edstam JS, Dulmaa N, Nymadawa P, Rinchin A, Khulan J, Kimball AM.
Comparison of hepatitis B vaccine coverage and effectiveness among urban and
rural Mongolian 2-year-olds. Prev Med. 2002 Feb;34(2):207-14.
4630.
Fong TL, Bunnapradist S, Jordan SC, Cho YW. Impact of hepatitis B core
antibody status on outcomes of cadaveric renal transplantation: analysis of
United network of organ sharing database between 1994 and 1999. Transplantation.
2002 Jan 15;73(1):85-9.
4631.
Frese M, Schwarzle V, Barth K, Krieger N, Lohmann V, Mihm S, Haller O,
Bartenschlager R. Interferon-gamma inhibits replication of subgenomic and
genomic hepatitis C virus RNAs. Hepatology. 2002 Mar;35(3):694-703.
4632.
Furusyo N, Hayashi J, Kashiwagi K, Nakashima H, Nabeshima S, Sawayama Y,
Kinukawa N, Kashiwagi S. Hepatitis C virus (HCV) RNA level determined by
second-generation branched-DNA probe assay as predictor of response to
interferon treatment in patients with chronic HCV viremia. Dig Dis Sci. 2002
Mar;47(3):535-42.
4633.
Galun E, Eren R, Safadi R, Ashour Y, Terrault N, Keeffe EB, Matot E,
Mizrachi S, Terkieltaub D, Zohar M, Lubin I, Gopher J, Shouval D, Dagan S.
Clinical evaluation (phase I) of a combination of two human monoclonal
antibodies to HBV: safety and antiviral properties. Hepatology. 2002
Mar;35(3):673-9.
4634.
Garcia-Retortillo M, Forns X, Feliu A, Moitinho E, Costa J, Navasa M,
Rimola A, Rodes J. Hepatitis C
virus kinetics during and immediately after liver transplantation. Hepatology.
2002 Mar;35(3):680-7.
4635.
Goswami BB, Kulka M, Ngo D, Istafanos P, Cebula TA. A polymerase chain
reaction-based method for the detection of hepatitis A virus in produce and
shellfish. J Food Prot. 2002 Feb;65(2):393-402.
4636.
Grant MD. Antibody convergence along a common idiotypic axis in
immunodeficiency virus and hepatitis C virus infections. J Med Virol. 2002
Jan;66(1):13-21.
4637.
Green ST, Kinghorn GR, Goldberg DJ, Mohsen AH. The value of genitourinary
medicine clinics in the recognition and diagnosis of new cases of hepatitis C in
the United Kingdom. Int J STD AIDS. 2002 Jan;13(1):60-2.
4638.
Harris HE, Ramsay ME, Andrews N, Eldridge KP. Clinical course of
hepatitis C virus during the first decade of infection: cohort study. BMJ. 2002
Feb 23;324(7335):450-3.
4639.
Hino K, Basuni AA, Ireland J, Newell A, Mphahlele J, Smit EJ, Ngui SL,
Teo CG, Carman WF. Reappearance of hepatitis B surface antigen in
immunocompromised individuals: reinfection or reactivation? Dig Dis Sci. 2002
Feb;47(2):415-8.
4640.
Idilman R, De MN, Colantoni A, Nadir A, Van T. The effect of high dose
and short interval HBV vaccination in individuals with chronic hepatitis C. Am J
Gastroenterol. 2002 Feb;97(2):435-9.
4641.
Iino S. Natural history of hepatitis B and C virus infections. Oncology.
2002;62 Suppl 1:18-23. Review.
4642.
Jacobs RJ, Koff RS, Meyerhoff AS. The cost-effectiveness of vaccinating
chronic hepatitis C patients against hepatitis A. Am J Gastroenterol. 2002
Feb;97(2):427-34.
4643.
Joshi S, Cauch-Dudek K, Wanless IR, Lindor KD, Jorgensen R, Batts K,
Heathcote EJ. Primary biliary cirrhosis with additional features of autoimmune
hepatitis: response to therapy with ursodeoxycholic acid. Hepatology. 2002
Feb;35(2):409 13.
4644.
Jung MC, Pape GR. Immunology of hepatitis B infection. Lancet Infect Dis.
2002 Jan;2(1):43-50. Review.
4645.
King MD, Reznik DA, O'Daniels CM, Larsen NM, Osterholt D, Blumberg HM.
Human papillomavirus-associated oral warts among human immunodeficiency
virus-seropositive patients in the era of highly active antiretroviral therapy:
an emerging infection. Clin Infect Dis. 2002 Mar 1;34(5):641-8.
4646.
Lai MM. Hepatitis C virus proteins: direct link to hepatic oxidative
stress, steatosis, carcinogenesis and more. Gastroenterology. 2002
Feb;122(2):568-71. Review.
4647.
Lankarani KB, Taghavi AR, Agah S, Karimi A. Comparison of intradermal and
intramuscular administration of hepatitis B vaccine in neonates. Indian J
Gastroenterol 2001, 20(3), 94-6.
4648.
Laskus T, Radkowski M, Wilkinson J, Vargas H, Rakela J. The origin of
hepatitis C virus reinfecting transplanted livers: serum-derived versus
peripheral blood mononuclear cell-derived virus. J Infect Dis. 2002 Feb
15;185(4):417-21.
4649.
Latorre P, Rubbia-Brandt L, Giostra E, Abid K, Negro F. The 4,977-base
pair common deletion of mitochondrial DNA is not associated with steatosis in
chronic hepatitis C patients. Hepatology. 2002 Jan;35(1):239-40.
4650.
Lau
D. Therapy of chronic Hepatitis B. Gastroenterol Today 2000, 4(4), 172.
4651.
Lauer GM, Nguyen TN, Day CL, Robbins GK, Flynn T, McGowan K, Rosenberg
ES, Lucas M, Klenerman P, Chung RT, Walker BD.
Human immunodeficiency virus type 1-hepatitis C virus coinfection:
intraindividual comparison of cellular immune responses against two persistent
viruses. J Virol. 2002 Mar;76(6):2817-26.
4652.
Levy S, Herve C, Delacoux E, Erlinger S. Thiamine deficiency in hepatitis
C virus and alcohol-related liver diseases. Dig Dis Sci. 2002 Mar;47(3):543-8.
4653.
Macalalad AR, Snydman DR. GB virus C and mortality from HIV infection. N
Engl J Med. 2002 Jan 31;346(5):377-9.
4654.
Madison DL, Allen E, Deodhar A, Morrison L. Henoch-Schonlein purpura: a
possible complication of hepatitis C related liver cirrhosis. Ann Rheum Dis.
2002 Mar;61(3):281-2. Review.
4655.
Maguire D, Heaton ND, Smith HM. Failure of reactivation of hepatitis B
after liver transplantation in hepatitis B surface antigen-negative, core
antibody-positive recipients. Transplantation. 2002 Feb 15;73(3):481-2.
4656.
Mishra D, Singh R, Sibal A. Liver transplantation for fulminant hepatitis
A infection. Indian Pediatr. 2002 Feb;39(2):189-92.
4657.
Mistry SK, Burwell TJ, Chambers RM, Rudolph-Owen L, Spaltmann F, Cook WJ,
Morris SM Jr. Cloning of human agmatinase. An alternate path for polyamine
synthesis induced in liver by hepatitis B virus. Am J Physiol Gastrointest Liver
Physiol. 2002 Feb;282(2):G375-81.
4658.
Murrill CS, Weeks H, Castrucci BC, Weinstock HS, Bell BP, Spruill C,
Gwinn M. Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C
virus infection among injection drug users admitted to drug treatment in 6 US
cities. Am J Public Health. 2002 Mar;92(3):385-7.
4659.
Mutimer D. Positive suggestions about the anti-HBc positive donor. Gut.
2002 Jan;50(1):7-8.
4660.
Nelson DB. Effectiveness of manual cleaning and disinfection for the
elimination of hepatitis C virus from GI endoscopes. Am J Gastroenterol. 2002
Jan;97(1):204-6.
4661.
Novel ring-expanded nucleoside analogs exhibit potent and selective
inhibition of hepatitis B virus replication in cultured human hepatoblastoma
cells. Antiviral Res. 2002 Feb;53(2):159-64.
4662.
Okuda M, Li K, Beard MR, Showalter LA, Scholle F, Lemon SM, Weinman SA.
Mitochondrial injury, oxidative stress, and antioxidant gene expression are
induced by hepatitis C virus core protein. Gastroenterology. 2002
Feb;122(2):366-75.
4663.
Pandey CK, Singh N, Kumar V, Agarwal A, Singh PK. Typhoid, hepatitis E,
or typhoid and hepatitis E: the cause of fulminant hepatic failure--a diagnostic
dilemma. Crit Care Med. 2002 Feb;30(2):376-8.
4664.
Pennesi M, Torre G, Del Santo M, Sonzogni A. Glomerulonephritis after
recombinant hepatitis B vaccine. Pediatr Infect Dis J. 2002 Feb;21(2):172-3.
4665.
Persico M, De Marino F, Russo GD, Morante A, Rotoli B, Torella R, De
Renzo A. Efficacy of lamivudine to
prevent hepatitis reactivation in hepatitis B virus-infected patients treated
for non-Hodgkin lymphoma. Blood. 2002 Jan 15;99(2):724-5.
4666.
Podzorski RP. Molecular testing in the diagnosis and management of
hepatitis C virus infection. Arch Pathol Lab Med. 2002 Mar;126(3):285-90.
Review.
4667.
Quadri R, Giostra E, Roskams T, Pawlotsky JM, Mentha G, Rubbia-Brandt L,
Perrin L, Hadengue A, Negro F. Immunological
and virological effects of ribavirin in hepatitis C after liver transplantation.
Transplantation. 2002 Feb 15;73(3):373-8.
4668.
Renge RL, Dani VS, Chitambar SD, Arankalle VA. Fulminant hepatitis A in
children with sickle cell disease. Indian Pediatr. 2002 Feb;39(2):186-9.
4669.
Romero MA, Seoane J, Varela-Centelles P, Diz-Dios P, Otero XL. Clinical
and pathological characteristics of oral lichen planus in hepatitis C-positive
and negative patients. Clin
Otolaryngol. 2002 Feb;27(1):22-6.
4670.
Roque-Afonso AM, Feray C, Samuel D, Simoneau D, Roche B, Emile JF, Gigou
M, Shouval D, Dussaix E. Antibodies to hepatitis B surface antigen prevent viral
reactivation in recipients of liver grafts from anti-HBC positive donors. Gut.
2002 Jan;50(1):95-9.
4671.
Rosenberg PM, Farrell JJ, Abraczinskas DR, Graeme-Cook FM, Dienstag JL,
Chung RT. Rapidly progressive
fibrosing cholestatic hepatitis--hepatitis C virus in HIV coinfection. Am J
Gastroenterol. 2002 Feb;97(2):478-83.
4672.
Sarmiento OL, Ford CL, Newbern EC, Miller WC, Poole C, Kaufman JS. The
importance of assessing effect modification when asserting racial differences in
associations between human leukocyte antigen class II alleles and hepatitis C
virus outcomes. J Infect Dis. 2002 Jan 15;185(2):266-8.
4673.
Schlaak JF, Schramm C, Radecke K, zum Buschenfelde KH, Gerken G.
Sustained suppression of HCV replication and inflammatory activity after
interleukin-2 therapy in patients with HIV/hepatitis C virus coinfection. J
Acquir Immune Defic Syndr. 2002 Feb 1;29(2):145-8.
4674.
Sherman KE, Rouster SD, Chung RT, Rajicic N. Hepatitis C Virus prevalence
among patients infected with Human Immunodeficiency Virus: a cross-sectional
analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis. 2002 Mar
15;34(6):831-7.
4675.
Shirin H, Davidovitz Y, Avni Y, Petchenko P, Krepel Z, Bruck R, Meytes D.
Prevalence of hepatitis C virus infection in patients with
lymphoproliferative disorders. Isr Med Assoc J. 2002 Jan;4(1):24-7.
4676.
Singh S K, Aggarwal A. Hepatitis B – one step ahead over AIDS.
Antiseptic, Madurai 2001, 98(7), 270-5.
4677.
Stein K, Rosenberg W, Wong J. Cost effectiveness of combination therapy
for hepatitis C: a decision analytic model. Gut. 2002 Feb;50(2):253-8.
4678.
Sulkowski MS, Thomas DL, Mehta SH, Chaisson RE, Moore RD. Hepatotoxicity
associated with nevirapine or efavirenz-containing antiretroviral therapy: role
of hepatitis C and B infections. Hepatology. 2002 Jan;35(1):182-9.
4679.
Thibault V, Aubron-Olivier C, Agut H, Katlama C. Primary infection with a
lamivudine-resistant hepatitis B virus. AIDS. 2002 Jan 4;16(1):131-3.
4680.
Thibault V, Candotti D, Autran B, Cahour A, Agut H. Hepatitis C virus
infection in long-term nonprogressor HIV-1-infected subjects. J Acquir Immune
Defic Syndr. 2002 Feb 1;29(2):204-6.
4681.
Torti C, Patroni A, Tinelli C, Sleiman I, Quiros-Roldan E, Puoti M,
Castelli F. Influence of hepatitis
C virus coinfection on lipid abnormalities in HIV-positive patients after highly
active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002 Mar
1;29(3):315-7.
4682.
van Steenbergen JE, Niesters HG, Op de Coul EL, van Doornum GJ, Osterhaus
AD, Leentvaar-Kuijpers A, Coutinho RA, van den Hoek JA. Molecular epidemiology
of hepatitis B virus in Amsterdam 1992-1997. J Med Virol. 2002 Feb;66(2):159-65.
4683.
Vardas E, Ross MH, Sharp G, McAnerney J, Sim J. Viral hepatitis in South
African healthcare workers at increased risk of occupational exposure to
blood-borne viruses. J Hosp Infect. 2002 Jan;50(1):6-12.
4684.
Vargas HE, Dodson FS, Rakela J. A concise update on the status of liver
transplantation for hepatitis B virus: the challenges in 2002. Liver Transpl.
2002 Jan;8(1):2-9. Review.
4685.
Vertuani S, Bazzaro M, Gualandi G, Micheletti F, Marastoni M, Fortini C,
Canella A, Marino M, Tomatis R, Traniello S, Gavioli R. Effect of
interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in
hepatitis C virus-infected individuals. Eur J Immunol. 2002 Jan;32(1):144-54.
4686.
Vohra
P. Chronic viral hepatitis and its management in children. Paediat Today 2001,
4(2), 70-80.JBT
4687.
Waris G, Siddiqui A. Interaction between STAT-3 and HNF-3 leads to the
activation of liver-specific hepatitis B virus enhancer 1 function. J Virol.
2002 Mar;76(6):2721-9.
4688.
Zylberberg
H, Nalpas B, Carnot F, Skhiri H, Fontaine H, Legendre C, Kreis H, Brechot C, Pol
S. Severe evolution of chronic hepatitis C in renal transplantation: a case
control study. Nephrol Dial Transplant. 2002 Jan;17(1):129-33.
Oct
02
5354.
Ali G, Kumar M, Bali SK, Wadhwa WB, Hepatitis E associated immune
thrombocytopaenia and membranous glomerulonephritis. Indian J Nephrol. 2001;
11(2), 70-2.
5355.
Anselmo DM, Ghobrial RM, Jung LC, Weaver M, Cao C, Saab S, Kunder G, Chen
PW, Farmer DG, Yersiz H, Baquerizo A, Geevarghese S, Han SH, Goldstein L, Holt
CD, Gornbein JA, Busuttil RW. New era of liver transplantation for hepatitis B:
a 17-year single-center experience. Ann Surg. 2002 May;235(5):611-9; discussion
619-20.
5356.
Armstrong GL, Bell BP. Hepatitis A virus infections in the United States:
model-based estimates and implications for childhood immunization. Pediatrics.
2002 May;109(5):839-45.
5357.
Arthur MJ. Reversibility of liver fibrosis and cirrhosis following
treatment for hepatitis C. Gastroenterology. 2002 May;122(5):1525-8.
5358.
Bhaskara Rao PVR. Hepatitis-B vaccineall don’t need it. Homeopathic
Prestige. 2001; 17(8), 369-74.
5359.
Carpenter PA, Huang ML, McDonald GB. Activation of occult hepatitis B
from a seronegative patient after hematopoietic cell transplant: a cautionary
tale. Blood. 2002 Jun 1;99(11):4245-6.
5360.
Chandra s, Gupta CP. Antibacterial activity of medicinal plant Crateava
nurvala (bark) against bacterial strains causing urinary tract infection. Asian
J chem. 2001; 13(3), 1181-6.
5361.
Chatterjee C, Mitra K, Hazra SC, Banerjee D, Guha SK, Neogi DK.
Prevention of HCV infection among patient of chronic active hepatitis and
cirrhosis cases in Calcutta. Indian J Med Microbiol. 2001; 19(1), 46-7.
5362.
Chern JP, Lin KH. Hypoparathyroidism in transfusion-dependent patients
with beta-thalassemia. J Pediatr Hematol Oncol. 2002 May;24(4):291-3.
5363.
Chu CJ, Lok AS. Clinical significance of hepatitis B virus genotypes.
Hepatology. 2002 May;35(5):1274-6. Review.
5364.
Day CP. Non-alcoholic
steatohepatitis (NASH): where are we now and where are we going? Gut. 2002
May;50(5):585-8. Review.
5365.
Desai I, Aligetti M. Hepatitis G. Indian J Occup Hlth. 2001; 44(1), 30-1.
5366.
Dutta AK. IAP hepatitis B immunization schedule. Indian Pediat. 2001;
38(11), 1335-8.
5367.
Elliott JH, Kunze M, Torresi J. Hepatitis A vaccine failure. Lancet. 2002
Jun 1;359(9321):1948-9.
5368.
El-Serag HB, Everhart JE. Diabetes increases the risk of acute hepatic
failure. Gastroenterology. 2002 Jun;122(7):1822-8.
5369.
Enomoto M, Nishiguchi S. SEN viruses and treatment response in chronic
hepatitis C virus. Lancet. 2002 May 18;359(9319):1780-1.
5370.
Feitelson MA, Sun B, Satiroglu Tufan NL, Liu J, Pan J, Lian Z. Genetic
mechanisms of hepatocarcinogenesis. Oncogene. 2002 Apr 11;21(16):2593-604.
Review.
5371.
Gollar R. Studies on efficacy of ribozymes and DNA enzymes against X gene
of Hepatitis B Virus and HIV coreceptor CCR5. Department of Immunology,
Jawaharlal Nehru University, New Delhi. 2001.
5372.
Grant M. Secondary persistent infection with hepatitis C virus: a
challenge for adaptive immunity. Lancet. 2002 Apr 27;359(9316):1452.
5373.
Guido M, Fagiuoli S, Tessari G, Burra P, Leandro G, Boccagni P, Cillo U,
Naccarato R, Rugge M. Histology
predicts cirrhotic evolution of post transplant hepatitis C. Gut. 2002
May;50(5):697-700.
5374.
Guptan RC, Thakur V, Malhotra V, Sarin SK. Recombinant interferon therapy
in Indian children with HBV related chronic liver disease. Indian Pediatr. 2002
May;39(5):462-7.
5375.
Heathcote EJ. Overlap of autoimmune hepatitis and primary biliary
cirrhosis: an evaluation of a modified scoring system. Am J Gastroenterol. 2002
May;97(5):1090-2.
5376.
Irnich D et.al. Randomised trial of acupuncture compared with
conventional massage and “sham” laser acupuncture for treatment of chronic
neck pain. Selections BMJ – South Asia Edn. 2001; 17(7), 604-7.
5377.
Jacob John T, Abraham P. Hepatitis B in India: a review of disease
epidemiology. Indian Pediat. 2001; 38(11), 1318-25.
5378.
Kelly D, Skidmore S. Hepatitis C-Z: recent advances. Arch Dis Child. 2002
May;86(5):339-43. Review.
5379.
Lee PC, Hung CJ, Lin YJ, Wang JR, Jan MS, Lei HY. A role for chronic
parvovirus B19 infection in liver dysfunction in renal transplant recipients?
Transplantation. 2002 May 27;73(10):1635-9.
5380.
Liaw YF. Chronic hepatitis B guidelines: east versus west. Hepatology.
2002 Apr;35(4):979-81; discussion 981-2.
5381.
Malik AS. Complications of bacteriologically confirmed typhoid fever in
children. J Trop Pediatr. 2002 Apr;48(2):102-8.
5382.
Miedouge M, Chatelut M, Mansuy JM, Rostaing L, Malecaze F, Sandres-Saune
K, Boudet F, Puel J, Abbal M, Izopet J. Screening of blood from potential organ
and cornea donors for viruses. J Med Virol
2002 Apr;66(4):571-5
5383.
Muir AJ, Rockey DC. Acute HCV: the early bird catches the virus.
Gastroenterology. 2002 Apr;122(4):1176-7; discussion 1177-8.
5384.
Nafeesa F. Incidence of hepatitis C virus infection in alcoholic, post
transfusion and renal transplant subjects. Department of Microbiology, Osmania
University ; Hyderabad, 2001.
5385.
Pawlotsky JM. Molecular diagnosis of viral hepatitis. Gastroenterology.
2002 May;122(6):1554-68. Review.
5386.
Sanchez-Lombrana JL, Alvarez RP, Saez LR, Oliva NP, Martinez RM. Acute
hepatitis associated with cetirizine intake. J Clin Gastroenterol. 2002
Apr;34(4):493-5.
5387.
Stewart DE. Hepatic adverse reactions associated with nefazodone. Can J
Psychiatry. 2002 May;47(4):375-7.
5388.
Usuki N, Miyamoto T. Chronic
hepatic disease: usefulness of serial CT examinations. J Comput Assist Tomogr.
2002 May-Jun;26(3):418-21.
5389.
Vassileva ANA. Strategies for optimisation of Hepatitis B surface antigen
in Picha Pastoris. Department of Biochemistry, University of Mysore, Mysore;
2001
5390.
Xu DZ, Yan YP, Choi BC, Xu JQ, Men K, Zhang JX, Liu ZH, Wang FS. Risk
factors and mechanism of transplacental transmission of hepatitis B virus: a
case-control study. J Med Virol. 2002 May;67(1):20-6.
5391.
Younossi ZM, Diehl AM, Ong JP. Nonalcoholic fatty liver disease: an
agenda for clinical research. Hepatology. 2002 Apr;35(4):746-52. Review.
Pathogenesis:
5392.
Campo JV, McNabb J, Perel JM, Mazariegos GV, Hasegawa SL, Reyes J.
Kava-induced fulminant hepatic failure. J Am Acad Child Adolesc Psychiatry. 2002
Jun;41(6):631-2.
5393.
Carmichael M. Risking life to give life. Newsweek. 2002 Apr
22;139(16):53.
5394.
Castellote J, Gornals J, Lopez C, Xiol X. Acute tension hydrothorax: a
life-threatening complication of cirrhosis. J Clin Gastroenterol. 2002
May-Jun;34(5):588-9.
5395.
Chang MH. Viral mutants and
fulminant hepatitis. A dominant hepatitis B virus population defective in virus
secretion because of several S-gene mutations from a patient with fulminant
hepatitis. J Pediatr Gastroenterol Nutr. 2002 Apr;34(4):426.
5396.
Dieterich DT. Treatment of hepatitis C and anemia in human
immunodeficiency virus-infected patients. J Infect Dis. 2002 May 15;185 Suppl
2:S128-37. Review.
5397.
Dodi F, Alessandrini A, Camera M, Gaffuri L, Morandi N, Pagano G.
Stevens-Johnson syndrome in HIV patients treated with nevirapine: two case
reports. AIDS. 2002 May 24;16(8):1197-8.
5398.
Drago F, Rebora A. Cutaneous immunologic reactions to hepatitis B virus
vaccine. Ann Intern Med. 2002 May 21;136(10):780; discussion 780-1.
5399.
El-Zayadi AR, Selim O, Hamdy H, El-Tawil A, Moustafa H. Heavy cigarette
smoking induces hypoxic polycythemia (erythrocytosis) and hyperuricemia in
chronic hepatitis C patients with reversal of clinical symptoms and laboratory
parameters with therapeutic phlebotomy. Am J Gastroenterol. 2002
May;97(5):1264-5.
5400.
Griffiths A, Olynyk JK. Iron and the response to treatment of hepatitis
C. Am J Gastroenterol. 2002 Apr;97(4):788-90.
5401.
Gupta R, Singh S, Tang R, Blackwell TA, Schiffman JS. Anterior ischemic
optic neuropathy caused by interferon alpha therapy. Am J Med. 2002 Jun
1;112(8):683-4.
5402.
Hill JB, Sheffield JS, Kim MJ, Alexander JM, Sercely B, Wendel GD. Risk
of hepatitis B transmission in breast-fed infants of chronic hepatitis B
carriers. Obstet Gynecol. 2002 Jun;99(6):1049-52.
5403.
Holtzman JL. The effect of alcohol on acetaminophen hepatotoxicity. Arch
Intern Med. 2002 May 27;162(10):1193.
5404.
Jeantet D, Chemin I, Mandrand B, Zoulim F, Trepo C, Kay A.
Characterization of two hepatitis B virus populations isolated from a hepatitis
B surface antigen-negative patient. Hepatology. 2002 May;35(5):1215-24.
5405.
Kawa S, Ota M, Yoshizawa K, Horiuchi A, Hamano H, Ochi Y, Nakayama K,
Tokutake Y, Katsuyama Y, Saito S, Hasebe O, Kiyosawa K. HLA DRB10405-DQB10401
haplotype is associated with autoimmune pancreatitis in the Japanese population.
Gastroenterology. 2002 May;122(5):1264-9.
5406.
Kazim SN, Wakil SM, Khan LA, Hasnain SE, Sarin SK. Vertical transmission
of hepatitis B virus despite maternal lamivudine therapy. Lancet. 2002 Apr
27;359(9316):1488-9.
5407.
Kladney RD, Cui X, Bulla GA, Brunt EM, Fimmel CJ. Expression of GP73, a
resident Golgi membrane protein, in viral and nonviral liver disease.
Hepatology. 2002 Jun;35(6):1431-40.
5408.
Kondili LA, Chionne P, Costantino A, Villano U, Lo Noce C, Pannozzo F,
Mele A, Giampaoli S, Rapicetta M. Infection
rate and spontaneous seroreversion of anti-hepatitis C virus during the natural
course of hepatitis C virus infection in the general population. Gut. 2002
May;50(5):693-6.
5409.
Lauret E, Rodriguez M, Gonzalez S, Linares A, Lopez-Vazquez A,
Martinez-Borra J, Rodrigo L, Lopez-Larrea C. HFE gene mutations in alcoholic and
virus-related cirrhotic patients with hepatocellular carcinoma. Am J
Gastroenterol. 2002 Apr;97(4):1016-21.
5410.
Manesis EK, Papatheodoridis GV, Hadziyannis SJ. Serum HBV-DNA levels in
inactive hepatitis B virus carriers. Gastroenterology. 2002 Jun;122(7):2092-3;
discussion 2093.
5411.
Mazoff CD. Re: J. Gross editorial--"Hepatitis C: a sexually
transmitted disease?". Am J Gastroenterol. 2002 May;97(5):1256; discussion
1256-7.
5412.
Naoumov NV. SEN viruses and treatment response in chronic hepatitis C
virus. Lancet. 2002 May 18;359(9319):1779-80; discussion 1780.
5413.
Okan V, Araz M, Aktaran S, Karsligil T, Meram I, Bayraktaroglu Z, Demirci
F. Increased frequency of HCV but
not HBV infection in type 2 diabetic patients in Turkey. Int J Clin Pract. 2002
Apr;56(3):175-7.
5414.
Okita M, Sasagawa T, Tomioka K, Hasuda K, Ota Y, Suzuki K, Watanabe A.
Habitual food intake and polyunsaturated fatty acid deficiency in liver
cirrhosis. Nutrition. 2002 Apr;18(4):304-8.
5415.
Oviedo J, Wolfe MM. Alcohol, acetaminophen, and toxic effects on the
liver. Arch Intern Med. 2002 May 27;162(10):1194-5.
5416.
Patel PA, Voigt MD. Prevalence and interaction of hepatitis B and latent
tuberculosis in Vietnamese immigrants to the United States. Am J Gastroenterol.
2002 May;97(5):1198-203.
5417.
Radaeva S, Jaruga B, Hong F, Kim WH, Fan S, Cai H, Strom S, Liu Y,
El-Assal O, Gao B. Interferon-alpha activates multiple STAT signals and
down-regulates c-Met in primary human hepatocytes. Gastroenterology. 2002
Apr;122(4):1020-34.
5418.
Redondo-Cerezo E, Nogueras-Lopez F, Martin-Vivaldi R, Simon EE. Fulminant
hepatic failure as the presenting form of type 1 autoimmune hepatitis in the
elderly. Am J Gastroenterol. 2002 May;97(5):1265-6.
5419.
Ross RS, Viazov S, Roggendorf M. Phylogenetic analysis indicates
transmission of hepatitis C virus from an infected orthopedic surgeon to a
patient. J Med Virol. 2002 Apr;66(4):461-7.
5420.
Ross RS, Viazov S, Thormahlen M, Bartz L, Tamm J, Rautenberg P,
Roggendorf M, Deister A. Risk of hepatitis C virus transmission from an infected
gynecologist to patients: results of a 7-year retrospective investigation. Arch
Intern Med. 2002 Apr 8;162(7):805-10.
5421.
Singh N, Husain S, Carrigan DR, Knox KK, Weck KE, Wagener MM, Gayowski T.
Impact of human herpesvirus-6 on the frequency and severity of recurrent
hepatitis C virus hepatitis in liver transplant recipients. Clin Transplant.
2002 Apr;16(2):92-6.
5422.
Soll AH, Sees KL. Is
acetaminophen really safe in alcoholic patients? Arch Intern Med. 2002 May
27;162(10):1194.
5423.
Takahashi K, Kang JH, Ohnishi S, Hino K, Mishiro S. Genetic heterogeneity
of hepatitis E virus recovered from Japanese patients with acute sporadic
hepatitis. J Infect Dis. 2002 May 1;185(9):1342-5.
5424.
Tazawa J, Maeda M, Nakagawa M, Ohbayashi H, Kusano F, Yamane M, Sakai Y,
Suzuki K. Diabetes mellitus may be associated with hepatocarcinogenesis in
patients with chronic hepatitis C. Dig Dis Sci. 2002 Apr;47(4):710-5.
5425.
Thies N. Universal neonatal immunization for Hepatitis B. J Paediatr
Child Health. 2002 Apr;38(2):211; discussion 211-2.
5426.
Thorpe LE, Ouellet LJ, Hershow R, Bailey SL, Williams IT, Williamson J,
Monterroso ER, Garfein RS. Risk of
hepatitis C virus infection among young adult injection drug users who share
injection equipment. Am J Epidemiol. 2002 Apr 1;155(7):645-53.
5427.
Tsutsumi T, Suzuki T, Shimoike T, Suzuki R, Moriya K, Shintani Y, Fujie
H, Matsuura Y, Koike K, Miyamura T. Interaction
of hepatitis C virus core protein with retinoid X receptor alpha modulates its
transcriptional activity. Hepatology. 2002 Apr;35(4):937-46.
5428.
Volberding P, Sullivan P. Introduction: the importance of identifying and
treating complications of human immunodeficiency virus disease. J Infect Dis.
2002 May 15;185 Suppl 2:S103-4.
5429.
Woitas RP, Ahlenstiel G, Iwan A, Rockstroh JK, Brackmann HH, Kupfer B,
Matz B, Offergeld R, Sauerbruch T, Spengler U. Frequency of the HIV-protective
CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C.
Gastroenterology. 2002 Jun;122(7):1721-8.
5430.
Wong WH, Braunfeld M, Levin P. Recurrent pulmonary embolism during liver
transplantation: possible role of hepatitis B immune globulin as a causative
agent. Anesthesiology. 2002 May;96(5):1261-3.
5431.
Zepp F, Schuind A, Meyer C, Sanger R, Kaufhold A, Willems P. Safety and
reactogenicity of a novel DTPa-HBV-IPV combined vaccine given along with
commercial Hib vaccines in comparison with separate concomitant administration
of DTPa, Hib, and OPV vaccines in infants. Pediatrics. 2002 Apr;109(4):e58.
Vaccines:
5432.
Barnes-Nelson N. Doctors say all newborns need Hepatitis B shot. J Natl
Med Assoc. 2002 Apr;94(4):A12.
5433.
Paul Y. Hepatitis B
immunization schedule recommended by IAP. Indian Pediatr. 2002 May;39(5):503-4;
discussion 504-5.
5434.
Ray S, Samuel T, Hawker J, Smith S. Hepatitis B immunisation in renal
units in the United Kingdom: questionnaire study. BMJ. 2002 Apr
13;324(7342):877-8.
5435.
Shiao JS, Mclaws ML, Huang KY, Guo YL. Student nurses in Taiwan at high
risk for needlestick injuries. Ann Epidemiol. 2002 Apr;12(3):197-201.
Drugs
:
5436.
Fuller CM, Vlahov D, Ompad DC, Shah N, Arria A, Strathdee SA. High-risk
behaviors associated with transition from illicit non-injection to injection
drug use among adolescent and young adult drug users: a case-control study. Drug
Alcohol Depend. 2002 Apr 1;66(2):189-98.